Top compounds associated with response to ACTL7B


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.05 0.3
mRNA tivozanib CTRPv2 pan-cancer AAC -0.051 0.2
mRNA tivozanib GDSC1000 pan-cancer AAC 0.024 0.5
mRNA tosedostat CTRPv2 pan-cancer AAC -0.0052 0.9
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.027 0.4
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.045 0.2
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.025 0.4
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.02 0.6
mRNA triptolide CTRPv2 pan-cancer AAC 0.016 0.7
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.036 0.5
Download CSV